Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
35.08 BRL | +17.78% |
|
+0.92% | +24.44% |
07-02 | BRITISH AMERICAN TOBACCO : UBS remains Neutral | ZD |
06-28 | US urges dismissal of lawsuit seeking menthol cigarette ban | RE |
Summary
- Overall, the company has poor fundamentals for a medium to long-term investment strategy.
Strengths
- Before interest, taxes, depreciation and amortization, the company's margins are particularly high.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Its low valuation, with P/E ratio at 7.71 and 7.19 for the ongoing fiscal year and 2025 respectively, makes the stock pretty attractive with regard to earnings multiples.
- The company appears to be poorly valued given its net asset value.
- Given the positive cash flows generated by its business, the company's valuation level is an asset.
- The company is one of the best yield companies with high dividend expectations.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- According to Standard & Poor's' forecast, revenue growth prospects are expected to be very low for the next fiscal years.
- The potential for earnings per share (EPS) growth in the coming years appears limited according to current analyst estimates.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- With an enterprise value anticipated at 3.26 times the sales for the current fiscal year, the company turns out to be overvalued.
- For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
- Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
Ratings chart - Surperformance
Sector: Tobacco
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+24.44% | 68.62B | - | ||
+8.04% | 157B | B- | ||
+11.49% | 21.73B | A- | ||
+32.62% | 7.44B | B- | ||
+103.69% | 2.65B | - | C+ | |
-2.30% | 1.8B | - | ||
-3.90% | 1.72B | - | D+ | |
-28.92% | 1.17B | - | B+ | |
0.00% | 646M | - | - | |
+26.18% | 571M | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BATS Stock
- B1TI34 Stock
- Ratings British American Tobacco p.l.c.